BDBM264470 6-([1,1'-biphenyl]-2-yloxy)-2-(thiazol-2-yl)-3,4-dihydro-2H-benzo[e][1,2]thiazine 1,1-dioxide::US9714252, 6

SMILES O=S1(=O)N(CCc2cc(Oc3ccccc3-c3ccccc3)ccc12)c1nccs1

InChI Key InChIKey=MWVJDHLZAOUROB-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 264470   

TargetSodium channel protein type 9 subunit alpha(Human)
Purdue Pharma

US Patent
LigandPNGBDBM264470(6-([1,1'-biphenyl]-2-yloxy)-2-(thiazol-2-yl)-3,4-d...)
Affinity DataIC50: 1.70E+3nMAssay Description:Representative Compounds of the Invention have been tested in the FLIPR, FLIPRTETRA, and/or electrophysiology (EP) assays for sodium channel blocking...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/15/2018
Entry Details
Go to US Patent